Line 7: | Line 7: | ||
<div class="column full_size" > | <div class="column full_size" > | ||
− | <h2> Welcome to iGEM | + | <h2> Welcome to iGEM Team Hannover´s Wiki! </h2> |
− | + | ||
− | </div> | + | </div> |
− | <h3>★ | + | <div class="column half_size" > |
+ | <div class="highlight"> | ||
+ | <h3>★ Enable the usage of TAL-effector proteins in-vitro </h3> | ||
<p>TAL (Transcription Activator Like) –effector proteins are a new possibility for genetic engineering. Due to a special, repeating sequence of amino acids, a so-called repeat domain, TAL-effectors can easily bind to a certain DNA sequence and perform various functions. | <p>TAL (Transcription Activator Like) –effector proteins are a new possibility for genetic engineering. Due to a special, repeating sequence of amino acids, a so-called repeat domain, TAL-effectors can easily bind to a certain DNA sequence and perform various functions. | ||
</p><p> | </p><p> | ||
Line 20: | Line 21: | ||
Our aim is to develop a circular TAL-effector with the help of a linker in order to stabilize the protein. Thereby, TAL-effectors could be utilized on a daily basis and enable new techniques of genetic engineering in the lab. | Our aim is to develop a circular TAL-effector with the help of a linker in order to stabilize the protein. Thereby, TAL-effectors could be utilized on a daily basis and enable new techniques of genetic engineering in the lab. | ||
</p> | </p> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
</div> | </div> | ||
</div> | </div> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
<div class="column half_size" > | <div class="column half_size" > | ||
− | + | </div > | |
− | + | ||
− | + | ||
− | + | ||
− | </div> | + | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
<div class="button_click" onClick=" parent.location= 'https://2016.igem.org/Special:Upload '"> | <div class="button_click" onClick=" parent.location= 'https://2016.igem.org/Special:Upload '"> | ||
Line 95: | Line 33: | ||
</div> | </div> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
</html> | </html> |
Revision as of 19:46, 29 August 2016
Welcome to iGEM Team Hannover´s Wiki!
★ Enable the usage of TAL-effector proteins in-vitro
TAL (Transcription Activator Like) –effector proteins are a new possibility for genetic engineering. Due to a special, repeating sequence of amino acids, a so-called repeat domain, TAL-effectors can easily bind to a certain DNA sequence and perform various functions.
Originally, those proteins were discovered in Xanthomonas. Those bacteria use TAL-effectors to specifically regulate host genes. After decoding the amino-acid-code of TAL-effectors, genetic changes can be generated. In this way, DNA-fragments can be replaced and precisely cut or foreign DNA can be inserted.
TAL-effector proteins offer a significant advantage compared to usual procedures e.g. with restriction enzymes: Trough an easy change of the amino acid sequence, the protein can be customized to any DNA sequence. The function of TAL-effectors could be proven in vivo in cell cultures and also in animals. However, they show a high instability outside living organisms. This instability leads to the problem that the purification of TAL-effectors as well as the in-vitro application in the lab is difficult to perform. For this reason, TAL-effector proteins are excluded from a huge field of application, because a lot of genetic work usually takes place “in test tubes”.
Our aim is to develop a circular TAL-effector with the help of a linker in order to stabilize the protein. Thereby, TAL-effectors could be utilized on a daily basis and enable new techniques of genetic engineering in the lab.